{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:09:33Z","timestamp":1790669373442,"version":"4.1.0"},"reference-count":130,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HAB"],"published-print":{"date-parts":[[2020,2,13]]},"DOI":"10.3233\/hab-190392","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T13:38:22Z","timestamp":1563889102000},"page":"57-64","source":"Crossref","is-referenced-by-count":1,"title":["Cellular immune responses against cancer-germline genes in cancers"],"prefix":"10.1177","volume":"28","author":[{"given":"Sepideh","family":"Dashti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Taherian-Esfahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/HAB-190392_ref1","first-page":"395","article-title":"Cancer-testis antigens: potential targets for cancer immunotherapy","volume":"12","author":"Ghafouri-Fard","year":"2009","journal-title":"Archives of Iranian Medicine"},{"key":"10.3233\/HAB-190392_ref2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5812\/ircmj.3611","article-title":"Expression of testis specific genes TSGA10, TEX101 and ODF3 in breast cancer","volume":"14","author":"Dianatpour","year":"2012","journal-title":"Iranian Red Crescent Medical Journal"},{"key":"10.3233\/HAB-190392_ref3","doi-asserted-by":"crossref","first-page":"e38783","DOI":"10.1371\/journal.pone.0038783","article-title":"NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer","volume":"7","author":"Ademuyiwa","year":"2012","journal-title":"PloS One"},{"key":"10.3233\/HAB-190392_ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.arcmed.2010.04.003","article-title":"Expression of two testis-specific genes, SPATA19 and LEMD1, in prostate cancer","volume":"41","author":"Ghafouri-Fard","year":"2010","journal-title":"Archives of Medical Research"},{"key":"10.3233\/HAB-190392_ref5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2133.2009.09568.x","article-title":"Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features","volume":"162","author":"Ghafouri-Fard","year":"2010","journal-title":"British Journal of Dermatology"},{"key":"10.3233\/HAB-190392_ref6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.7314\/APJCP.2014.15.6.2395","article-title":"Bladder cancer biomarkers: review and update","volume":"15","author":"Ghafouri-Fard","year":"2014","journal-title":"Asian Pac J Cancer P"},{"key":"10.3233\/HAB-190392_ref7","doi-asserted-by":"crossref","unstructured":"Z. Taherian-Esfahani et al., Cancer-testis antigens: a novel group of tumor biomarkers in ovarian cancers, Iran J Cancer Prev 9 (Dec, 2016).","DOI":"10.17795\/ijcp-4993"},{"key":"10.3233\/HAB-190392_ref8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/pme-2018-0049","article-title":"Expression analysis of a panel of cancer-testis antigens in bladder cancer","volume":"15","author":"Yazarlou","year":"2018","journal-title":"Pers Med"},{"key":"10.3233\/HAB-190392_ref9","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/bcj.2012.32","article-title":"Cancer-testis antigen expression and immunogenicity in AL amyloidosis","volume":"2","author":"Rosenzweig","year":"2012","journal-title":"Blood Cancer Journal"},{"key":"10.3233\/HAB-190392_ref10","first-page":"7","article-title":"The frequent expression of cancer\/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma","volume":"4","author":"Ayyoub","year":"2004","journal-title":"Cancer Immunity Archive"},{"key":"10.3233\/HAB-190392_ref11","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.7314\/APJCP.2012.13.12.5947","article-title":"Cancer stem cells and response to therapy","volume":"13","author":"Tabarestani","year":"2012","journal-title":"Asian Pac J Cancer P"},{"key":"10.3233\/HAB-190392_ref12","first-page":"471","article-title":"Upregulation of RHOXF2 and ODF4 expression in breast cancer tissues","volume":"17","author":"Kazemi-Oula","year":"2015","journal-title":"Cell Journal (Yakhteh)"},{"key":"10.3233\/HAB-190392_ref13","first-page":"320","article-title":"Outer dense fiber proteins: bridging between male infertility and cancer","volume":"20","author":"Azizi","year":"2017","journal-title":"Archives of Iranian Medicine"},{"key":"10.3233\/HAB-190392_ref14","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.7314\/APJCP.2013.14.11.6625","article-title":"Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines","volume":"14","author":"Seifi-Alan","year":"2013","journal-title":"Asian Pac J Cancer P"},{"key":"10.3233\/HAB-190392_ref15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5144\/0256-4947.2012.256","article-title":"Expression of testis-specific genes, TEX101 and ODF4, in chronic myeloid leukemia and evaluation of TEX101 immunogenicity","volume":"32","author":"Ghafouri-Fard","year":"2012","journal-title":"Ann Saudi Med"},{"key":"10.3233\/HAB-190392_ref16","first-page":"967","article-title":"Cancer\/testis genes in relation to sperm biology and function","volume":"20","author":"Babatunde","year":"2017","journal-title":"Iran J Basic Med Sci"},{"key":"10.3233\/HAB-190392_ref17","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.7314\/APJCP.2015.16.13.5149","article-title":"Expression of cancer-testis antigens in pediatric cancers","volume":"16","author":"Ghafouri-Fard","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.3233\/HAB-190392_ref18","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/CMAR.S180389","article-title":"Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma","volume":"10","author":"Yazarlou","year":"2018","journal-title":"Cancer Management and Research"},{"key":"10.3233\/HAB-190392_ref19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.187.2.265","article-title":"Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes","volume":"187","author":"Jager","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref20","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.7314\/APJCP.2014.15.18.7703","article-title":"Are so-called cancer-testis genes expressed only in testis","volume":"15","author":"Ghafouri-Fard","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.3233\/HAB-190392_ref21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1348-0421.2005.tb03688.x","article-title":"Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells","volume":"49","author":"Okumura","year":"2005","journal-title":"Microbiology and Immunology"},{"key":"10.3233\/HAB-190392_ref22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/pros.21400","article-title":"Identification of AKAP-4 as a new cancer\/testis antigen for detection and immunotherapy of prostate cancer","volume":"72","author":"Chiriva-Internati","year":"2012","journal-title":"The Prostate"},{"key":"10.3233\/HAB-190392_ref23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1074-7613(95)80053-0","article-title":"BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes","volume":"2","author":"Bo\u00ebl","year":"1995","journal-title":"Immunity"},{"key":"10.3233\/HAB-190392_ref24","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1158\/1078-0432.CCR-04-0475","article-title":"Identification of a novel human cancer\/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses","volume":"10","author":"Monji","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/HAB-190392_ref25","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.23823","article-title":"HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL","volume":"123","author":"Harao","year":"2008","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/CJI.0b013e3181a1d109","article-title":"Cep55\/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma","volume":"32","author":"Inoda","year":"2009","journal-title":"Journal of Immunotherapy"},{"key":"10.3233\/HAB-190392_ref27","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.177.4.2717","article-title":"Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancers","volume":"177","author":"Janjic","year":"2006","journal-title":"The Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0215(19990730)82:3<442::AID-IJC19>3.0.CO;2-Z","article-title":"Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1","volume":"82","author":"Aarnoudse","year":"1999","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref29","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.4049\/jimmunol.165.12.7253","article-title":"Efficient simultaneous presentation of NY-ESO-1\/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma","volume":"165","author":"Rimoldi","year":"2000","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref30","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.4049\/jimmunol.161.7.3596","article-title":"A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames","volume":"161","author":"Wang","year":"1998","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00262-005-0066-x","article-title":"A new LAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-A68 tumors","volume":"55","author":"Sun","year":"2006","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.3233\/HAB-190392_ref32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.cgt.7700674","article-title":"Induction of CAMEL\/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5\/35 fiber","volume":"11","author":"Slager","year":"2004","journal-title":"Cancer Gene Therapy"},{"key":"10.3233\/HAB-190392_ref33","doi-asserted-by":"crossref","unstructured":"G. Zeng, X. Wang, P.F. Robbins, S.A. Rosenberg and R.F. Wang, CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production, Proceedings of the National Academy of Sciences of the United States of America 98 (Mar 27, 2001), 3964.","DOI":"10.1073\/pnas.061507398"},{"key":"10.3233\/HAB-190392_ref34","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.4049\/jimmunol.172.8.5095","article-title":"Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1\/Th2 lymphocytes","volume":"172","author":"Slager","year":"2004","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.191.4.625","article-title":"Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma","volume":"191","author":"Jager","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref36","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.170.3.1490","article-title":"CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame","volume":"170","author":"Slager","year":"2003","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(03)00359-5","article-title":"Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"key":"10.3233\/HAB-190392_ref38","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1158\/1078-0432.CCR-05-1900","article-title":"In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.3233\/HAB-190392_ref39","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1182\/blood-2011-07-365890","article-title":"Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen","volume":"119","author":"Ochsenreither","year":"2012","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","article-title":"A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma","volume":"182","author":"Van den Eynde","year":"1995","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref41","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/j.1349-7006.2009.01200.x","article-title":"Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer","volume":"100","author":"Kono","year":"2009","journal-title":"Cancer Science"},{"key":"10.3233\/HAB-190392_ref42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.leukres.2004.09.013","article-title":"Serological identification of immunogenic antigens in acute monocytic leukemia","volume":"29","author":"Chen","year":"2005","journal-title":"Leukemia Research"},{"key":"10.3233\/HAB-190392_ref43","first-page":"466","article-title":"Bioinformatic analysis and identification for a novel antigen MLAA-22 in acute monocytic leukemia","volume":"16","author":"Zhou","year":"2008","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.3233\/HAB-190392_ref44","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/j.1349-7006.2007.00603.x","article-title":"Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy","volume":"98","author":"Suda","year":"2007","journal-title":"Cancer Science"},{"key":"10.3233\/HAB-190392_ref45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.176.5.1453","article-title":"A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E","volume":"176","author":"Traversari","year":"1992","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref46","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s00262-005-0705-2","article-title":"A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells","volume":"54","author":"Ottaviani","year":"2005","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.3233\/HAB-190392_ref47","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.4049\/jimmunol.163.5.2928","article-title":"Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1","volume":"163","author":"Chaux","year":"1999","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref48","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1034\/j.1399-0039.2000.550206.x","article-title":"A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes","volume":"55","author":"Luiten","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0039.2000.560110.x","article-title":"A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules","volume":"56","author":"Luiten","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref50","first-page":"2668","article-title":"Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family","volume":"59","author":"Tanzarella","year":"1999","journal-title":"Cancer Res"},{"key":"10.3233\/HAB-190392_ref51","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.0001-2815.2004.00203.x","article-title":"Identification of a MAGE-1 peptide recognized by cytolytic T lymphocytes on HLA-B*5701 tumors","volume":"63","author":"Corbiere","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref52","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/eji.1830240930","article-title":"Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601","volume":"24","author":"van der Bruggen","year":"1994","journal-title":"European Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00262-006-0230-y","article-title":"Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family","volume":"56","author":"Wang","year":"2007","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.3233\/HAB-190392_ref54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.189.5.767","article-title":"Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes","volume":"189","author":"Chaux","year":"1999","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref55","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/1521-4141(200106)31:6<1910::AID-IMMU1910>3.0.CO;2-K","article-title":"A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells","volume":"31","author":"Chaux","year":"2001","journal-title":"European Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref56","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.4049\/jimmunol.162.11.6849","article-title":"Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma","volume":"162","author":"Huang","year":"1999","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref57","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1002\/eji.1830241218","article-title":"A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3","volume":"24","author":"van der Bruggen","year":"1994","journal-title":"European Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref58","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.4049\/jimmunol.164.11.6041","article-title":"Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12","volume":"164","author":"Heidecker","year":"2000","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref59","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4049\/jimmunol.172.4.2232","article-title":"Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses","volume":"172","author":"Breckpot","year":"2004","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref60","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00262-012-1298-1","article-title":"Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay","volume":"61","author":"Akiyama","year":"2012","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.3233\/HAB-190392_ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0198-8859(97)00255-3","article-title":"The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors","volume":"59","author":"Kawashima","year":"1998","journal-title":"Human Immunology"},{"key":"10.3233\/HAB-190392_ref62","first-page":"2236","article-title":"Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes","volume":"5","author":"Tahara","year":"1999","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.3233\/HAB-190392_ref63","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood-2008-04-149393","article-title":"Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1\/A2\/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma","volume":"112","author":"Goodyear","year":"2008","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.179.3.921","article-title":"Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes","volume":"179","author":"Gaugler","year":"1994","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref65","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<387::AID-IJC12>3.0.CO;2-Z","article-title":"A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes","volume":"81","author":"Oiso","year":"1999","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000091185","article-title":"A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells","volume":"70","author":"Miyagawa","year":"2006","journal-title":"Oncology"},{"key":"10.3233\/HAB-190392_ref67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1034\/j.1399-0039.2002.600103.x","article-title":"A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18","volume":"60","author":"Bilsborough","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1399-0039.2001.057002103.x","article-title":"A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes","volume":"57","author":"Schultz","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.20011974","article-title":"The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome","volume":"195","author":"Schultz","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF02199806","article-title":"A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3","volume":"43","author":"Herman","year":"1996","journal-title":"Immunogenetics"},{"key":"10.3233\/HAB-190392_ref71","doi-asserted-by":"crossref","unstructured":"V. Russo et al., Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response, Proceedings of the National Academy of Sciences of the United States of America 97 (Feb 29, 2000), 2185.","DOI":"10.1073\/pnas.040540197"},{"key":"10.3233\/HAB-190392_ref72","first-page":"6272","article-title":"A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes","volume":"60","author":"Schultz","year":"2000","journal-title":"Cancer Res"},{"key":"10.3233\/HAB-190392_ref73","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4049\/jimmunol.172.2.1304","article-title":"Functional analysis of tumor-specific Th cell responses detected in melanoma patients after dendritic cell-based immunotherapy","volume":"172","author":"Schultz","year":"2004","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4049\/jimmunol.171.1.219","article-title":"A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein","volume":"171","author":"Zhang","year":"2003","journal-title":"Journal of Immunology (Baltimore, Md.: 1950)"},{"key":"10.3233\/HAB-190392_ref75","first-page":"4773","article-title":"Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles","volume":"61","author":"Kobayashi","year":"2001","journal-title":"Cancer Res"},{"key":"10.3233\/HAB-190392_ref76","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood-2002-03-0933","article-title":"Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3","volume":"101","author":"Consogno","year":"2003","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref77","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.189.5.871","article-title":"Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11","volume":"189","author":"Manici","year":"1999","journal-title":"The Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref78","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00262-010-0916-z","article-title":"MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes","volume":"60","author":"Cesson","year":"2011","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"key":"10.3233\/HAB-190392_ref79","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1034\/j.1399-0039.2003.00123.x","article-title":"New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells","volume":"62","author":"Kobayashi","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref80","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1002\/(SICI)1521-4141(199910)29:10<3329::AID-IMMU3329>3.0.CO;2-7","article-title":"A MAGE-A4 peptide presented by HLA-A2 is recognized by cytolytic T lymphocytes","volume":"29","author":"Duffour","year":"1999","journal-title":"European Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref81","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1158\/1078-0432.CCR-04-2585","article-title":"Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE","volume":"11","author":"Miyahara","year":"2005","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"key":"10.3233\/HAB-190392_ref82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1034\/j.1399-0039.2002.600503.x","article-title":"A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes","volume":"60","author":"Zhang","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.3233\/HAB-190392_ref83","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00262-011-1009-3","article-title":"Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma","volume":"60","author":"Anderson","year":"2011","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.3233\/HAB-190392_ref84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1084\/jem.20041379","article-title":"High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens","volume":"201","author":"Germeau","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref85","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2008.05.049","article-title":"Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587","volume":"372","author":"Xing","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.3233\/HAB-190392_ref86","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.20038","article-title":"Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2","volume":"109","author":"Ma","year":"2004","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref87","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00262-006-0244-5","article-title":"A new tumor-specific antigen encoded by MAGE-C2 and presented to cytolytic T lymphocytes by HLA-B44","volume":"56","author":"Godelaine","year":"2007","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.3233\/HAB-190392_ref88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.25058","article-title":"NY-CO-58\/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer","volume":"127","author":"Gnjatic","year":"2010","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref89","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jjco\/hys069","article-title":"Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer","volume":"42","author":"Obara","year":"2012","journal-title":"Japanese Journal of Clinical Oncology"},{"key":"10.3233\/HAB-190392_ref90","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.lungcan.2008.12.020","article-title":"Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity","volume":"65","author":"Nakamura","year":"2009","journal-title":"Lung Cancer"},{"key":"10.3233\/HAB-190392_ref91","doi-asserted-by":"crossref","unstructured":"J. Matsuzaki et al., Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer, Proceedings of the National Academy of Sciences 107 (2010), 7875.","DOI":"10.1073\/pnas.1003345107"},{"key":"10.3233\/HAB-190392_ref92","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood-2011-09-379982","article-title":"Cancer\/testis antigens are novel targets of immunotherapy for adult T-cell leukemia\/lymphoma","volume":"119","author":"Nishikawa","year":"2012","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref93","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-2141.2012.09225.x","article-title":"Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity","volume":"158","author":"Toor","year":"2012","journal-title":"British Journal of Haematology"},{"key":"10.3233\/HAB-190392_ref94","first-page":"3","article-title":"A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy","volume":"13","author":"Gupta","year":"2013","journal-title":"Cancer Immunity Archive"},{"key":"10.3233\/HAB-190392_ref95","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1158\/1078-0432.CCR-04-0819","article-title":"NY-ESO-1 expression and immunogenicity in esophageal cancer","volume":"10","author":"Fujita","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/HAB-190392_ref96","first-page":"10","article-title":"NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer","volume":"3","author":"Nakada","year":"2003","journal-title":"Cancer Immunity Archive"},{"key":"10.3233\/HAB-190392_ref97","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-04-0181","article-title":"Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma","volume":"10","author":"Korangy","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/HAB-190392_ref98","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1158\/1078-0432.CCR-04-0502","article-title":"The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients","volume":"10","author":"Shang","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/HAB-190392_ref99","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ijc.22698","article-title":"Identification of cytotoxic T-lymphocyte epitope (s) and its agonist epitope (s) of a novel target for vaccine therapy (PAGE4)","volume":"121","author":"Yokokawa","year":"2007","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2141.2009.07761.x","article-title":"Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma","volume":"146","author":"Ait-Tahar","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.3233\/HAB-190392_ref101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3324\/haematol.2010.028241","article-title":"CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma","volume":"96","author":"Ait-Tahar","year":"2011","journal-title":"haematologica"},{"key":"10.3233\/HAB-190392_ref102","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00726-011-0966-3","article-title":"Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer","volume":"42","author":"Liu","year":"2012","journal-title":"Amino Acids"},{"key":"10.3233\/HAB-190392_ref103","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.3233\/HAB-190392_ref104","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-05-2578","article-title":"Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy","volume":"12","author":"Griffioen","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/HAB-190392_ref105","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1182\/blood-2008-03-144071","article-title":"Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia","volume":"113","author":"Rezvani","year":"2009","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref106","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1182\/blood-2010-08-300376","article-title":"High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells","volume":"117","author":"Quintarelli","year":"2011","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref107","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/1521-4141(200108)31:8<2277::AID-IMMU2277>3.0.CO;2-Z","article-title":"Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk","volume":"31","author":"Chiriva-Internati","year":"2001","journal-title":"European Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref108","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.10506","article-title":"Tumor vaccine for ovarian carcinoma targeting sperm protein 17","volume":"94","author":"Chiriva-Internati","year":"2002","journal-title":"Cancer: Interdisciplinary International Journal of the American Cancer Society"},{"key":"10.3233\/HAB-190392_ref109","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ijc.11486","article-title":"Identification of a sperm protein 17 CTL epitope restricted by HLA-A1","volume":"107","author":"Chiriva-Internati","year":"2003","journal-title":"International Journal of Cancer"},{"key":"10.3233\/HAB-190392_ref110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jim.2007.01.010","article-title":"A NOD\/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17","volume":"321","author":"Chiriva-Internati","year":"2007","journal-title":"Journal of Immunological Methods"},{"key":"10.3233\/HAB-190392_ref111","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/10428190801911688","article-title":"Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma","volume":"49","author":"Frank","year":"2008","journal-title":"Leukemia & Lymphoma"},{"key":"10.3233\/HAB-190392_ref112","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1078-0432.CCR-08-1290","article-title":"Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells","volume":"15","author":"Almanzar","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/HAB-190392_ref113","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00262-006-0269-9","article-title":"Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals","volume":"56","author":"Godefroy","year":"2007","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.3233\/HAB-190392_ref114","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4049\/jimmunol.174.3.1709","article-title":"Naturally acquired MAGE-A10-and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma","volume":"174","author":"Bricard","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref115","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.4049\/jimmunol.174.8.5092","article-title":"CD4+ T cell responses to SSX-4 in melanoma patients","volume":"174","author":"Ayyoub","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.3233\/HAB-190392_ref116","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood-2005-04-1487","article-title":"Identification of an epitope derived from the cancer testis antigen HOM-TES-14\/SCP1 and presented by dendritic cells to circulating CD4+ T cells","volume":"106","author":"Neumann","year":"2005","journal-title":"Blood"},{"key":"10.3233\/HAB-190392_ref117","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/0008-5472.CAN-03-2209","article-title":"Identification of novel and widely expressed cancer\/testis gene isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to melanoma","volume":"64","author":"Hogan","year":"2004","journal-title":"Cancer Res"},{"key":"10.3233\/HAB-190392_ref118","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1349-7006.2008.00844.x","article-title":"Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma","volume":"99","author":"Mizukami","year":"2008","journal-title":"Cancer Science"},{"key":"10.3233\/HAB-190392_ref119","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1084\/jem.191.9.1617","article-title":"A processed pseudogene codes for a new antigen recognized by a CD8+ T cell clone on melanoma","volume":"191","author":"Moreau-Aubry","year":"2000","journal-title":"Journal of Experimental Medicine"},{"key":"10.3233\/HAB-190392_ref120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2249.2008.03724.x","article-title":"A dendritic cell-based tumour vaccine for lung cancer: Full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro","volume":"153","author":"Zhou","year":"2008","journal-title":"Clinical & Experimental Immunology"},{"key":"10.3233\/HAB-190392_ref121","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/imt.15.3","article-title":"New york esophageal squamous cell carcinoma-1 and cancer immunotherapy","volume":"7","author":"Esfandiary","year":"2015","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref122","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2217\/imt.15.29","article-title":"MAGE-A3: an immunogenic target used in clinical practice","volume":"7","author":"Esfandiary","year":"2015","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref123","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/imt.13.165","article-title":"Cancer-testis genes as candidates for immunotherapy in breast cancer","volume":"6","author":"Ghafouri-Fard","year":"2014","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref124","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2217\/imt-2017-0083","article-title":"Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy","volume":"9","author":"Faramarzi","year":"2017","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2217\/imt.12.29","article-title":"Immunotherapy in nonmelanoma skin cancer","volume":"4","author":"Ghafouri-Fard","year":"2012","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref126","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/imt-2017-0091","article-title":"Melanoma: a prototype of cancer-testis antigen-expressing malignancies","volume":"9","author":"Faramarzi","year":"2017","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref127","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2217\/imt-2017-0154","article-title":"Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma","volume":"10","author":"Seifi-Alan","year":"2018","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref128","doi-asserted-by":"crossref","unstructured":"S. Ghafouri-Fard, M. Seifi-Alan, R. Shamsi and A. Esfandiary, Immunotherapy in multiple myeloma using cancer-testis antigens, Iran J Cancer Prev 8 (Oct, 2015).","DOI":"10.17795\/ijcp-3755"},{"key":"10.3233\/HAB-190392_ref129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/imt.11.145","article-title":"Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy","volume":"4","author":"Ghafouri-Fard","year":"2012","journal-title":"Immunotherapy"},{"key":"10.3233\/HAB-190392_ref130","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/08820139.2016.1197241","article-title":"Cancer\/testis antigens: expression, regulation, tumor invasion, and use in immunotherapy of cancers","volume":"45","author":"Salmaninejad","year":"2016","journal-title":"Immunological Investigations"}],"container-title":["Human Antibodies"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/HAB-190392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:15Z","timestamp":1777447335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/HAB-190392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":130,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/hab-190392","relation":{},"ISSN":["1875-869X","1093-2607"],"issn-type":[{"value":"1875-869X","type":"electronic"},{"value":"1093-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,13]]}}}